Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Gorovits

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Immunological Methods|May 28, 2014
Recommendations for the characterization of immunogenicity response to multiple domain biotherapeuticsBoris Gorovits, Eric Wakshull, Renuka Pillutla, et al.
Journal of Clinical Pharmacology|August 3, 2004
Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemiaMary Buckwalter, James A Dowell, Joan Korth-Bradley, et al.
The AAPS Journal|April 27, 2013
Pre-existing biotherapeutic-reactive antibodies: survey results within the American Association of Pharmaceutical ScientistsLi Xue, Michele Fiscella, Manoj Rajadhyaksha, et al.
The AAPS Journal|February 6, 2020
Correction to: Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.
The AAPS Journal|January 8, 2020
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.
The AAPS Journal|June 4, 2020
Development of a Highly Specific Anti-drug Antibody Assay in Support of a Nanoparticle-based TherapeuticYing Wang, Judith F Smith, Marcela M Araya, et al.
The AAPS Journal|December 29, 2017
Calibration Curves in Quantitative Ligand Binding Assays: Recommendations and Best Practices for Preparation, Design, and Editing of Calibration CurvesMitra Azadeh, Boris Gorovits, John Kamerud, et al.
The AAPS Journal|March 14, 2020
Development of a Cell-Based Assay for the Detection of Neutralizing Antibodies to PF-06730512 Using Homogenous Time-Resolved FluorescenceMichael Luong, Ying Wang, Stephen P Berasi, et al.
Bioanalysis|September 18, 2020
Strategies to develop highly drug-tolerant cell-based neutralizing antibody assay: neutralizing antidrug antibodies extraction and drug depletionZhihua Jiang, John Kamerud, Minlei Zhang, et al.
Bioanalysis|July 19, 2021
Feasibility of singlicate-based analysis in bridging ADA assay on Meso-Scale Discovery platform: comparison with duplicate analysisZhihua Jiang, John Kamerud, Zhiping You, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Immunological Methods|May 28, 2014
Recommendations for the characterization of immunogenicity response to multiple domain biotherapeuticsBoris Gorovits, Eric Wakshull, Renuka Pillutla, et al.
Journal of Clinical Pharmacology|August 3, 2004
Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemiaMary Buckwalter, James A Dowell, Joan Korth-Bradley, et al.
The AAPS Journal|April 27, 2013
Pre-existing biotherapeutic-reactive antibodies: survey results within the American Association of Pharmaceutical ScientistsLi Xue, Michele Fiscella, Manoj Rajadhyaksha, et al.
The AAPS Journal|February 6, 2020
Correction to: Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.
The AAPS Journal|January 8, 2020
Recommendations for the Development of Cell-Based Anti-Viral Vector Neutralizing Antibody AssaysBoris Gorovits, Michele Fiscella, Mike Havert, et al.
The AAPS Journal|June 4, 2020
Development of a Highly Specific Anti-drug Antibody Assay in Support of a Nanoparticle-based TherapeuticYing Wang, Judith F Smith, Marcela M Araya, et al.
The AAPS Journal|December 29, 2017
Calibration Curves in Quantitative Ligand Binding Assays: Recommendations and Best Practices for Preparation, Design, and Editing of Calibration CurvesMitra Azadeh, Boris Gorovits, John Kamerud, et al.
The AAPS Journal|March 14, 2020
Development of a Cell-Based Assay for the Detection of Neutralizing Antibodies to PF-06730512 Using Homogenous Time-Resolved FluorescenceMichael Luong, Ying Wang, Stephen P Berasi, et al.
Bioanalysis|September 18, 2020
Strategies to develop highly drug-tolerant cell-based neutralizing antibody assay: neutralizing antidrug antibodies extraction and drug depletionZhihua Jiang, John Kamerud, Minlei Zhang, et al.
Bioanalysis|July 19, 2021
Feasibility of singlicate-based analysis in bridging ADA assay on Meso-Scale Discovery platform: comparison with duplicate analysisZhihua Jiang, John Kamerud, Zhiping You, et al.
Pageof 8